Potential Protective and Therapeutic Role of Immune Checkpoint Inhibitors Against Viral Infections and COVID-19
Lidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, Alba A. Brandes
Abstract
The issue whether to continue or delay immunotherapy during the coronavirus outbreak is crucial, since these agents may be detrimental in the case of virus-related pneumonia, but at the same time they are quite effective and potentially curative in cancer, especially in melanoma.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyMedicineImmune systemImmunologyImmune checkpointImmunotherapyInfectious disease (medical specialty)DiseaseOutbreakPathologyCancer Immunotherapy and BiomarkersCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impacts